Art-based Beauty Appreciation Intervention (ABBA-vention)

August 15, 2025 updated by: Radboud University Medical Center

RCT Pilot Study: Art-based Beauty Appreciation Intervention

This study is a randomized controlled trial with an active control condition evaluating the impact of an art-based beauty appreciation (ABBA) intervention on trait appreciation of beauty as a primary outcome and well-being and psychological distress as secondary outcomes. The central hypothesis is that the primary and secondary outcomes will increase more in the intervention than in the control condition.

Study Overview

Detailed Description

This study is a randomized controlled trial with an active control condition evaluating the impact of an art-based beauty appreciation (ABBA) intervention on trait appreciation of beauty as a primary outcome and well-being and psychological distress as secondary outcomes. These two programs have been designed and validated in a qualitative pilot study as matched in credibility, intensity, and enjoyment. There are three measurement points for primary and secondary outcomes, including (1) enrollment, (2) a post-test after the intervention/control program, and (3) a 4-week follow-up measure. N = 114 participants will be randomized after baseline into either the intervention or control group (N = 57/group). In addition, to investigate perceived mechanisms, barriers, and facilitators, participants will be selected using purposive sampling and invited to a semi-structured interview until data saturation is reached (expected N = 15).

Study Type

Interventional

Enrollment (Actual)

114

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nijmegen, Netherlands, 6525 GA
        • Radboudumc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Participants must be between 18-28 years of age,
  2. indicate that they have a smartphone to support our data collection and program components,
  3. have the ability and interest to make a trip to a museum or new location (i.e., new part of the city),

(3) be willing to complete short activities every day for two weeks, (4) and be fluent in English, (6) be based in Amsterdam, (7) are willing to share postal address to receive materials.

Exclusion Criteria:

  1. Participants must not currently be in clinical treatment for a mental health disorder, assessed via self-report, or
  2. indicate that they are currently experiencing severe psychological symptoms (i.e., depression, suicidal ideation, severe anxiety) via self-report.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active Control Condition
The active, matched control group will focus on developing pragmatic observation skills. Participants will be instructed to pay attention to and identify objects and elements in their surroundings without emphasizing their aesthetic value. For example, they should pay attention and count objects of the same colour they encounter, social behaviour, the people they pass on the street, or the types of buildings. The 14-day program includes a tourist trip with guided audio instruction, watching instructional videos about increasing observation skills and completing daily written or photo journals to document their observations. Further, participants will take an observation walk and plan to include more observation in their lives.
Other: Intervention Condition
The goals of the intervention program are to help individuals develop an aesthetic mindset, practice observation and appreciation skills, learn how to apply these skills to their day-to-day lives, practice emotion regulation with beauty, and incorporate more beauty into their lives. The program is designed to create a slow skill transfer from appreciation in art contexts to natural beauty and to everyday life. In the 14-day program, participants visit an art museum with guided audio, watch instructional videos about observing and appreciating beauty, and complete daily written or photo beauty journals that document the beauty they see. In addition, participants will watch video art showing how to find beauty in mundane objects, practice this in a beauty walk, and complete a planning session to include more beauty in their lives.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engagement with Beauty
Time Frame: From baseline to the follow-up period (up to 2 months)
The Engagement with Beauty Scale Revised (EBS-R) is an 18-item self-report scale designed to assess cognitive and emotional engagement with natural beauty, artistic beauty, moral beauty, and beautiful ideas. Participants respond on a 7-point Likert scale, ranging from 1 (very unlike me) to 7 (very much like me). Example items include reflections on physiological responses to natural beauty, the spiritual experience elicited by art, and the desire for personal growth through moral beauty appreciation. Subscales measure engagement with moral beauty (scores 6-42) and the other three domains (scores 4-28), contributing to a total score ranging from 18 to 126.
From baseline to the follow-up period (up to 2 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being
Time Frame: From baseline to the follow-up period (up to 2 months)
We will measure well-being using the Mental Health Continuum Short Form (MHC-SF). This has 14 items over three subscales: emotional well-being, social well-being (eudemonic well-being), and psychological well-being. The items are scored on a 6-point Likert scale (0-5), then sum-scored.
From baseline to the follow-up period (up to 2 months)
Psychological Distress
Time Frame: From baseline to the follow-up period (up to 2 months)
The DASS-21 will be used to measure psychological distress. It has 21 items divided over three subscales of 7 items each. These capture emotional states of depression, anxiety, and stress. The items are assessed using a four-point Likert scale (0-3), summed together, and multiplied by two. This results in three subscales and a total score.
From baseline to the follow-up period (up to 2 months)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotion Regulation via Beauty
Time Frame: From baseline to the follow-up period (up to 2 months)
The Emotion Regulation Strategies for Artistic Creative Activities Scale (ERS-ACA; Fancourt et al., 2019) will be used with slight modification to the question stem. While the initial purpose of this scale was geared towards creative pursuits, it has been rooted in the principles of emotion regulation theory and designed to be applied to various activities. We anticipate that it will be a valuable instrument in evaluating how appreciating beauty can regulate emotions. This change in the question stem concerns the use of the prompt, "When I am appreciating beauty…". Items can be added up to avoidance strategies (i.e., I can block out unwanted thoughts or feelings), approach strategies (i.e., it makes me reflect on my emotions), and self-development strategies (i.e., it reaffirms my identity).
From baseline to the follow-up period (up to 2 months)
Attention Regulation
Time Frame: From baseline to the follow-up period (up to 2 months)
Attention regulation will be assessed using the 20-item Attention Control Scale (ACS) (Derryberry & Reed, 2002). The questionnaire consists of 2 subscales: (1) Attention Focusing and (2) Attention Shifting. The items are assessed on a four-point Likert scale (1-4) and will be sum-scored.
From baseline to the follow-up period (up to 2 months)
Mindfulness Skills
Time Frame: From baseline to the follow-up period (up to 2 months)
Mindfulness will be assessed using the Five Facet Mindfulness Questionnaire Short Form (FFMQ-15), with 15 items (Baer, Carmody, & Hunsinger, 2012), with five facets: (1) observing, (2) describing, (3) acting with awareness, (4) non-judging, and (5) non-reactivity (Baer et al., 2006). The items are assessed on a five-point Likert scale (1-5) from rarely to always. Scores will be summed for each facet and the total score.
From baseline to the follow-up period (up to 2 months)
Burnout
Time Frame: From baseline to the follow-up period (up to 2 months)
Burnout will be measured using the Burnout Assessment Tool-12 (BAT-12), consisting of 12 items (Redelinghuys & Morgan, 2023; Schaufeli et al., 2020). This questionnaire measures burnout with four subscales: (1) Exhaustion, (2) Mental Distance, (3) Emotional Impairment, and (4) Cognitive Impairment (Schaufeli et al., 2020). The items are assessed on a five-point Likert scale (1-5). A total score can be obtained by calculating all items' average scores. Additionally, subscale scores are obtained by calculating the average of the items per subscale.
From baseline to the follow-up period (up to 2 months)
Qualitative Interview
Time Frame: After timepoint 3 (8-9 weeks after enrollment)
Semi-structured interview focusing on the impacts of intervention, mechanisms, barriers and facilitators.
After timepoint 3 (8-9 weeks after enrollment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: MacKenzie D Trupp, PhD Candidate, RadboudUMC, Donders Institute for Brain, Cognition and Behaviour and University of Vienna
  • Principal Investigator: Corina Greven, Prof. Dr., RadboudUMC, Donders Institute for Brain, Cognition and Behaviour

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2024

Primary Completion (Actual)

July 18, 2025

Study Completion (Actual)

July 18, 2025

Study Registration Dates

First Submitted

December 22, 2024

First Submitted That Met QC Criteria

January 22, 2025

First Posted (Actual)

January 23, 2025

Study Record Updates

Last Update Posted (Actual)

August 17, 2025

Last Update Submitted That Met QC Criteria

August 15, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All identifying information will remain in storage within the RadboudUMC storage systems at the Donders Institute and will not be shared. Data will not be published; however, it will be stored in the Radboud Repository, where further researchers can request access to pseudonymized data after signing a data-access agreement.

IPD Sharing Time Frame

The study pre-registration will be embargoed on Open Science Framework (OSF) until the publication of the results in an academic journal.

IPD Sharing Access Criteria

After the release from the embargo, anyone can access the pre-registration on OSF.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Young Adults

Clinical Trials on Observation Program (Learning to Observe Life)

Subscribe